148 related articles for article (PubMed ID: 33838977)
1. Re: Unilateral axillary adenopathy in the setting of COVID-19 vaccine, Clinical Imaging, January 2021.
Finnegan J; Govender P; Torreggiani WC
Clin Imaging; 2021 Jul; 75():171-172. PubMed ID: 33838977
[No Abstract] [Full Text] [Related]
2. COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT.
Lane DL; Neelapu SS; Xu G; Weaver O
Korean J Radiol; 2021 Dec; 22(12):1938-1945. PubMed ID: 34719892
[TBL] [Abstract][Full Text] [Related]
3. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine.
Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
Clin Imaging; 2021 Jul; 75():12-15. PubMed ID: 33486146
[TBL] [Abstract][Full Text] [Related]
4. Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up.
Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
Clin Imaging; 2021 Dec; 80():83-87. PubMed ID: 34298342
[TBL] [Abstract][Full Text] [Related]
5. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
Smith MV; Yang M
J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
[TBL] [Abstract][Full Text] [Related]
6. Axillary adenopathy following COVID-19 vaccination: A single institution case series.
Duke H; Posch L; Green L
Clin Imaging; 2021 Dec; 80():111-116. PubMed ID: 34303188
[TBL] [Abstract][Full Text] [Related]
7. Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines.
Brown A; Shah S; Dluzewski S; Musaddaq B; Wagner T; Szyszko T; Wan S; Groves A; Mokbel K; Malhotra A
Clin Radiol; 2021 Aug; 76(8):553-558. PubMed ID: 34053731
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma.
Avner M; Orevi M; Caplan N; Popovtzer A; Lotem M; Cohen JE
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2659-2660. PubMed ID: 33675368
[No Abstract] [Full Text] [Related]
10. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
[TBL] [Abstract][Full Text] [Related]
11. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
12. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer.
Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR
Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962
[TBL] [Abstract][Full Text] [Related]
13. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D
Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women.
Mortazavi S
AJR Am J Roentgenol; 2021 Oct; 217(4):857-858. PubMed ID: 33624520
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings.
Nguyen DL; Ambinder EB; Myers KS; Mullen LA; Panigrahi B; Oluyemi E
AJR Am J Roentgenol; 2022 Jun; 218(6):997-998. PubMed ID: 34935404
[TBL] [Abstract][Full Text] [Related]
16. Axillary Adenopathy in Patients with Recent Covid-19 Vaccination: A New Diagnostic Dilemma.
Ashoor A; Shephard J; Lissidini G; Nicosia L
Korean J Radiol; 2021 Dec; 22(12):2124-2126. PubMed ID: 34825530
[No Abstract] [Full Text] [Related]
17. COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma.
Prieto PA; Mannava K; Sahasrabudhe DM
Lancet Oncol; 2021 Jun; 22(6):e281. PubMed ID: 34087152
[No Abstract] [Full Text] [Related]
18. Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination.
Horvat JV; Sevilimedu V; Becker AS; Perez-Johnston R; Yeh R; Feigin KN
Eur Radiol; 2022 Aug; 32(8):5752-5758. PubMed ID: 35247087
[TBL] [Abstract][Full Text] [Related]
19. Post COVID-19 vaccine adenopathy: first Brazilian report.
Viana JA; Fonseca EKUN; Sawamura MVY
J Bras Pneumol; 2021 Aug; 47(4):e20210206. PubMed ID: 34406229
[No Abstract] [Full Text] [Related]
20. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination.
Robinson KA; Maimone S; Gococo-Benore DA; Li Z; Advani PP; Chumsri S
JAMA Oncol; 2021 Sep; 7(9):1395-1397. PubMed ID: 34292295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]